Changes in Serum S100ß, NSE, and LP-PLA2 Levels and Their Association with Prognosis in Patients with Hypertensive Basal Ganglia Hemorrhage

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2500099158

Enrollment

Unknown

Registered

2025-03-19

Start date

2025-03-20

Completion date

Unknown

Last updated

2025-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertensive Basal Ganglia Hemorrhage

Interventions

GCSscore(12-15):None

GCSscore(9-11):None

GCSscore(3-8):None

Eligibility

Sex/Gender

All

Age

50 Years to 80 Years

Inclusion criteria

Inclusion criteria: Inclusion Criteria: 1 Age between 50 and 80 years old; 2 Confirmed by CT as a first-time occurrence of hypertensive intracerebral hemorrhage in the basal ganglia; 3 Within 72 hours of symptom onset; 4 Meets the diagnostic criteria for hypertensive intracerebral hemorrhage in the basal ganglia; 5 Signed informed consent form.

Exclusion criteria

Exclusion criteria: Exclusion Criteria: 1 Age 80 years; 2 Modified Rankin Scale (mRS) score = 3 before onset of illness; 3 Malignant tumors; 4 Severe organ diseases of the heart, liver, kidneys, etc.; 5 Intracerebral hemorrhage caused by other factors such as vascular malformations or intracranial tumors.

Design outcomes

Primary

Measure	Time frame
s100ß;NSE;LP-PLA2;	—

Countries

China

Contacts

Public ContactDecai Zhu

Bozhou People's Hospital

zhudcgn@163.com+86 189 5678 9335

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026